Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Other Non-Current Assets (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Other Non-Current Assets for 5 consecutive years, with $674000.0 as the latest value for Q2 2025.

  • For Q2 2025, Other Non-Current Assets fell 89.67% year-over-year to $674000.0; the TTM value through Jun 2025 reached $674000.0, down 89.67%, while the annual FY2024 figure was $2.4 million, 56.84% down from the prior year.
  • Other Non-Current Assets hit $674000.0 in Q2 2025 for Kezar Life Sciences, roughly flat from $674000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $6.6 million in Q2 2023 and bottomed at $282000.0 in Q1 2021.
  • Average Other Non-Current Assets over 5 years is $2.5 million, with a median of $674000.0 recorded in 2022.
  • Year-over-year, Other Non-Current Assets skyrocketed 2226.95% in 2023 and then crashed 89.67% in 2025.
  • Kezar Life Sciences' Other Non-Current Assets stood at $282000.0 in 2021, then surged by 139.01% to $674000.0 in 2022, then skyrocketed by 730.12% to $5.6 million in 2023, then plummeted by 56.84% to $2.4 million in 2024, then plummeted by 72.09% to $674000.0 in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $674000.0, $674000.0, and $2.4 million for Q2 2025, Q1 2025, and Q4 2024 respectively.